Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 801 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Long-Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis with Polyangiitis
Michael E Wechsler,Jared Silver, Gerhard Wolff,Robert G Price,Rejina Verghis,Peter F Weller,Peter A Merkel,Paneez Khoury, EGPA Mepolizumab Open‐Label Extension study group
Arthritis & rheumatology (Hoboken, NJ) (2025)
Cited0Views0WOSBibtex
0
0
Clinical Manifestations and Treatment in Patients with Relapsing Polychondritis: A Multicenter Observational Cohort Study
Roger Yang,Rennie L Rhee, Kaitlin A Quinn, Naomi A Amudala, Carol A McAlear,Peter C Grayson,Peter A Merkel, Marcela Ferrada,Shubhasree Banerjee, Vasculitis Clinical Research Consortium
ACR open rheumatologyno. 5 (2025): e70027-e70027
Cited0Views0WOSBibtex
0
0
Frailty and Associated Outcomes in Patients with Vasculitis
Sebastian E Sattui, John Stadler,Renee L Borchin,Cristina Burroughs, Laura Gandolfo,David Cuthbertson, Christine Yeung, Kalen Larson,Peter A Merkel,Robert Spiera, Vasculitis Patient-Powered Research Network
The Journal of rheumatology (2025)
Cited0Views0WOSBibtex
0
0
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
Daniel Blockmans, Sara K Penn, Arathi R Setty, Wolfgang A Schmidt,Andrea Rubbert-Roth, Ellen M Hauge, Helen I Keen,Tomonori Ishii,Nader Khalidi,Christian Dejaco,Maria C Cid,Bernhard Hellmich, Meng Liu, Weihan Zhao, Ivan Lagunes, Ana B Romero, Peter K Wung,Peter A Merkel, SELECT-GCA Study Group
The New England journal of medicineno. 20 (2025): 2013-2024
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 802

#Citation: 43107

H-Index: 92

G-Index: 200

Sociability: 8

Diversity: 3

Activity: 125

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn